Preferred Label : dabigatran etexilate mesylate;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 593282-20-3; SC7NUW5IIT;
Is substance : O;
UNII : SC7NUW5IIT;
InChIKey : XETBXHPXHHOLOE-UHFFFAOYSA-N;
Origin ID : M0557657;
UMLS CUI : C2343849;
CISMeF manual mappings
Exact mapping(s) to DCI
Related record
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/portail/jcms/c_2826822/fr/pradaxa
2018
false
false
false
false
France
French
evaluation of the transparency committee
dabigatran etexilate mesylate
Pradaxa
Dabigatran
Dabigatran
---
http://www.has-sante.fr/portail/jcms/c_2735608/fr/pradaxa
http://www.has-sante.fr/portail/jcms/c_2008301/fr/pradaxa
2016
true
France
French
postoperative venous thromboembolism
postoperative complications
venous thromboembolism
arthroplasty, replacement, hip
arthroplasty, replacement, knee
Dabigatran
Dabigatran
thrombin
aged
treatment outcome
insurance, health, reimbursement
administration, oral
stroke
dabigatran etexilate
embolism
antithrombins
atrial fibrillation
risk factors
adult
dabigatran etexilate mesylate
dabigatran etexilate mesylate
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2572151/fr/pradaxa
2015
false
France
French
venous thrombosis
venous thrombosis
deep vein thrombosis
deep vein thrombosis
pulmonary embolism
pulmonary embolism
recurrence
Dabigatran
Dabigatran
thrombin
treatment outcome
antithrombins
insurance, health, reimbursement
administration, oral
dabigatran etexilate
antithrombins
adult
dabigatran etexilate mesylate
dabigatran etexilate mesylate
evaluation of the transparency committee
---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/16387a-fra.php
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/16385a-fra.php
2012
false
Canada
French
English
Cardiotoxicity
Dabigatran
Contraindications, Procedure
dabigatran etexilate
administration, oral
antithrombins
heart valve prosthesis
heart valve diseases
clinical trials, phase ii as topic
thromboembolism
stroke
myocardial infarction
pharmacovigilance note
guidelines for drug use
dabigatran etexilate mesylate
thrombosis
Contraindications, Drug
---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/15855a-fra.php
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/17031a-fra.php
2012
false
Canada
English
French
Dabigatran
Dabigatran
Contraindications, Procedure
antithrombins
dabigatran etexilate
administration, oral
renal insufficiency
kidney function tests
antithrombins
thrombin
hemorrhage
adult
aged
risk assessment
heart valve prosthesis
mitral valve stenosis
rheumatic heart disease
dabigatran etexilate mesylate
dabigatran etexilate mesylate
guidelines for drug use
pharmacovigilance note
patient education handout
Contraindications, Drug
---
https://www.ema.europa.eu/medicines/human/EPAR/Pradaxa
2012
false
United Kingdom
French
English
syndication feed
Dabigatran
Dabigatran
drug approval
drug labeling
drug evaluation
treatment outcome
capsules
administration, oral
adult
postoperative complications
venous thrombosis
arthroplasty, replacement, hip
arthroplasty, replacement, knee
aged
drug interactions
pregnancy
prodrugs
drug evaluation, preclinical
dabigatran etexilate
antithrombins
antithrombins
dabigatran etexilate mesylate
dabigatran etexilate mesylate
drug evaluation
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63484283
2012
France
summary of product characteristics
capsules
dabigatran etexilate mesylate
---
http://www.has-sante.fr/portail/jcms/c_1250198/pradaxa-dabigatran-anticoagulant-oral
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
Dabigatran
Dabigatran
administration, oral
dabigatran etexilate mesylate
dabigatran etexilate mesylate
atrial fibrillation
stroke
embolism
antithrombins
antithrombins
thrombin
dabigatran etexilate
adult
aged
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/guide-dusage-optimal-sur-lanticoagulotherapie-par-le-dabigatran-pradaxamc-dans-le-traitement-de-la-fibrillation-auriculaire.html
2012
false
Canada
French
anticoagulotherapy
Dabigatran
Dabigatran
atrial fibrillation
anticoagulants
warfarin
drug interactions
hemorrhage
anticoagulants
dabigatran etexilate mesylate
dabigatran etexilate
dabigatran etexilate mesylate
guidelines for drug use
comparative study
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/pradaxa_15022012_avis_ct10749.pdf
http://www.has-sante.fr/portail/jcms/c_1221597/pradaxa
2012
false
France
French
Dabigatran
Dabigatran
thrombin
aged
treatment outcome
clinical trials, phase iii as topic
antithrombins
insurance, health, reimbursement
pharmacovigilance
hemorrhage
administration, oral
stroke
dabigatran etexilate
embolism
antithrombins
atrial fibrillation
risk factors
adult
dabigatran etexilate mesylate
dabigatran etexilate mesylate
evaluation of the transparency committee
---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14100a-fra.php
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14655a-fra.php
2011
false
Canada
French
English
pharmacovigilance note
Dabigatran
dabigatran etexilate mesylate
canada
medication errors
risk
platelet aggregation inhibitors
anticoagulants
administration, oral
dabigatran etexilate
clopidogrel
clopidogrel bisulfate
ticlopidine
Clopidogrel
---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F37F03B
2010
false
Belgium
French
anticoagulotherapy
Rivaroxaban
Dabigatran
venous thromboembolism
anticoagulants
administration, oral
dabigatran etexilate
postoperative complications
orthopedic procedures
treatment outcome
dabigatran etexilate mesylate
journal article
rivaroxaban
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00111
2008
false
Canada
French
English
Dabigatran
Dabigatran
administration, oral
dabigatran etexilate
anticoagulants
anticoagulants
venous thromboembolism
prodrugs
prodrugs
antithrombins
arthroplasty
postoperative complications
drug evaluation, preclinical
drug interactions
treatment outcome
dabigatran etexilate mesylate
dabigatran etexilate mesylate
drug information
---
http://www.has-sante.fr/portail/jcms/c_743928/synthese-d-avis-pradaxa-ct-5528
http://www.has-sante.fr/portail/jcms/c_698139/pradaxa
2008
false
France
French
evaluation of the transparency committee
Dabigatran
Dabigatran
thrombin
dabigatran etexilate
administration, oral
insurance, health, reimbursement
treatment outcome
antithrombins
antithrombins
adult
venous thromboembolism
postoperative complications
arthroplasty, replacement, hip
arthroplasty, replacement, knee
randomized controlled trials as topic
dabigatran etexilate mesylate
dabigatran etexilate mesylate
guidelines for drug use
---